Medical Management of BPH: The Debate Continues

European Urology

Volumn 50, Issue 3, 2006, Pages 416-417

  Debruyne, Frans M J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ENZYME INHIBITOR; PLACEBO; PLANT EXTRACT; PROSTATE SPECIFIC ANTIGEN; SABAL EXTRACT; STEROID 5ALPHA REDUCTASE INHIBITOR;

ALGORITHM; DIGITAL RECTAL EXAMINATION; EDITORIAL; GENERAL PRACTITIONER; HUMAN; PHYTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SABAL; SCORING SYSTEM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; MALE; PROSTATIC HYPERPLASIA;

EID: 33746881120     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.06.045     Document Type: Editorial

References (5)

1. Lowe F.C. Role of the newer alpha, adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clin Ther 26 (2004) 1701-1713
2. Debruyne F.M. Alpha blockers: are all created equal?. Urology 56 5 Suppl 1 (2000) 20-22
3. Kaplan S.A., McConnell J.D., Roehrborn C.G., Meehan A.G., Lee M.W., Noble W.R., Kusek J.W., and Nyberg Jr. L.M. Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J Urol 175 (2006) 217-220 discussion 220-1
4. Boyle P., Robertson C., Lowe F., and Roehrborn C. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. J Urol 173 (2005) 516
5. Jain S., and Mellon K. Re: Saw palmetto for benign prostatic hyperplasia. Eur Urol 50 (2006) 619